Protective Roles of Epithelial Cells in the Survival of Adult T-Cell Leukemia/Lymphoma Cells

被引:18
|
作者
Miyatake, Yukiko [1 ,3 ]
Oliveira, Andre L. A. [3 ,4 ]
Jarboui, Mohamed Ali [3 ]
Ota, Shuichi [5 ]
Tomaru, Utano [1 ]
Teshima, Takanori [2 ]
Hall, William W. [3 ]
Kasahara, Masanori [1 ]
机构
[1] Hokkaido Univ, Grad Sch Med, Dept Pathol, Sapporo, Hokkaido, Japan
[2] Hokkaido Univ, Grad Sch Med, Dept Hematol, Sapporo, Hokkaido, Japan
[3] Univ Coll Dublin, Sch Med & Med Sci, Ctr Res Infect Dis, Dublin 2, Ireland
[4] ICON Cent Labs, Dublin, Ireland
[5] Sapporo Hokuyu Hosp, Dept Hematol, Sapporo, Hokkaido, Japan
关键词
HISTONE DEACETYLASE INHIBITORS; IN-VITRO; LEUKEMIA-CELLS; HTLV-1; TAX; B-CELLS; APOPTOSIS; ACTIVATION; EXPRESSION; FEATURES; GROWTH;
D O I
10.1016/j.ajpath.2013.01.015
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Adult T-cell leukemia/lymphoma (ATL) is a highly invasive and intractable T-cell malignancy caused by human T-cell leukemia virus-1 infection. We demonstrate herein that normal tissue-derived epithelial cells (NECs) exert protective effects on the survival of leukemic cells, which may partially account for high resistance to antileukemic therapies in patients with ATL. Viral gene-silenced, ATL-derived cell Lines (ATL cells) dramatically escaped from histone deacetylase inhibitor-induced apoptosis by direct co-culture with NECs. Adhesions to NECs suppressed p21(Cip1) expression and increased a proportion of resting G0/G1 phase cells in trichostatin A (TSA)-treated ATL cells. ATL cells adhering to NECs down-regulated CD25 expression and enhanced vimentin expression, suggesting that most ATL cells acquired a quiescent state by cell-cell interactions with NECs. ATL cells adhering to NECs displayed highly elevated expression of the cancer stem cell marker CD44. Blockade of CD44 signaling diminished the NEC-conferred resistance of ATL cells to TSA-induced apoptosis. Co-culture with NECs also suppressed the expression of NKG2D Ligands on TSA-treated ATL cells, resulting in decreased natural killer cell-mediated cytotoxicity. Combined evidence suggests that interactions with normal epithelial cells augment the resistance of ATL cells to TSA-induced apoptosis and facilitate immune evasion by ATL cells.
引用
收藏
页码:1832 / 1842
页数:11
相关论文
共 50 条
  • [31] Genetic alterations in adult T-cell leukemia/lymphoma
    Kogure, Yasunori
    Kataoka, Keisuke
    CANCER SCIENCE, 2017, 108 (09): : 1719 - 1725
  • [32] Therapeutic Options for Adult T-Cell Leukemia/Lymphoma
    Marcais, Ambroise
    Suarez, Felipe
    Sibon, David
    Frenzel, Laurent
    Hermine, Olivier
    Bazarbachi, Ali
    CURRENT ONCOLOGY REPORTS, 2013, 15 (05) : 457 - 464
  • [33] MOGAMULIZUMAB FOR THE TREATMENT OF ADULT T-CELL LEUKEMIA/LYMPHOMA
    de Lartigue, J.
    DRUGS OF TODAY, 2012, 48 (10) : 655 - 660
  • [34] Molecular Pathology of Adult T-Cell Leukemia/Lymphoma
    Ohshima, Koichi
    ONCOLOGY, 2015, 89 : 7 - 15
  • [35] miRNA profiling in adult T-cell leukemia lymphoma (ATLL), a systems virology study
    Gouvarchinghaleh, Hadi Esmaeili
    Chenari, Maryam
    Farzanehpour, Mahdieh
    Yaghoobi, Mojtaba Hedayat
    Pourrezaei, Samira
    Bolandian, Masoumeh
    Mozhgani, Sayed-Hamidreza
    GENE REPORTS, 2021, 25
  • [36] Diagnosis and management of adult T-cell leukemia/lymphoma
    Ishitsuka, Kenji
    SEMINARS IN HEMATOLOGY, 2021, 58 (02) : 114 - 122
  • [37] Effects of tucidinostat in adult T-cell leukemia/lymphoma in clinical practice
    Kamiunten, Ayako
    Kameda, Takuro
    Sekine, Masaaki
    Kawano, Hiroshi
    Toyama, Takanori
    Akizuki, Keiichi
    Kawano, Noriaki
    Maeda, Kouichi
    Sato, Seiichi
    Takeuchi, Masanori
    Ishizaki, Junzo
    Nagamine, Koshiro
    Kuroki, Ayuka
    Ikeda, Ryoma
    Matsumoto, Kengo
    Karasawa, Masayoshi
    Tahira, Yuki
    Uchida, Taisuke
    Shimoda, Haruko
    Hidaka, Tomonori
    Yamashita, Kiyoshi
    Yamaguchi, Hideki
    Kubuki, Yoko
    Shimoda, Kazuya
    Shide, Kotaro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2025,
  • [38] Current Management of Adult T-Cell Leukemia/Lymphoma
    Tobinai, Kensei
    ONCOLOGY-NEW YORK, 2009, 23 (14): : 1250 - 1256
  • [39] Mogamulizumab for the Treatment of Adult T-cell Leukemia/Lymphoma
    Ureshino, Hiroshi
    Kamachi, Kazuharu
    Kimura, Shinya
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (06) : 326 - 331
  • [40] Promise of Combining a Bcl-2 Family Inhibitor with Bortezomib or SAHA for Adult T-cell Leukemia/Lymphoma
    Kunami, Naoko
    Katsuya, Hiroo
    Nogami, Rumiko
    Ishitsuka, Kenji
    Tamura, Kazuo
    ANTICANCER RESEARCH, 2014, 34 (10) : 5287 - 5294